随着意外过量服用的口袋药丸方法的弗莱卡因尼德毒性:一个案例报告
Mohamad Anas Oudih1, Avraham Ginsburg2, Mumin Hakim3,4
1Department of Internal Medicine, Montefiore Medical Center-Wakefield Campus, 600 E 233rd St, Bronx, NY 10466, USA.
在一款口袋药剂方案中意外过量服用弗莱卡因发生在患有心房动的患者身上. 碳酸有效地逆转了毒性,突出了它在管理飞胺过量剂量的重要性.
科学领域:
- 心脏病学 心脏病学
- 临床电生理学 临床电生理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 药丸在口袋 (PiP) 方法用于在特定患者的急性药理心脏转变.
- 弗莱卡尼德毒性很少见,特别是在PiP使用时,其管理没有得到充分记录.
研究的目的:
- 在使用PiP方法的患者中呈现意外过量使用 flecainide 的病例.
- 在此背景下,描述弗莱卡因毒性急性管理策略.
主要方法:
- 一名78岁的女性患有持续性心房动 (AF),接受了维拉帕米尔的治疗,通过PiP处方给她开了300毫克的flekainide.
- 由于慢性阻塞性肺部疾病和症状的恶化,患者自行服用多剂量flekainide.
- 治疗涉及静脉注射二碳酸 (玻尿酸和输液) 和糖酸盐.
主要成果:
- 患者在过量服用弗莱卡因尼德后出现了缓慢的AF和广泛的QRS复合体.
- 用二碳酸治疗导致QRS复合体在12小时内缩小.
- 鼻腔节律恢复,QRS间隔为136毫秒.
结论:
- 当剂量被强化时,使用 flecainide 的 PiP 策略可能是安全有效的.
- 意外的飞胺毒性可能危及生命,需要及时管理.
- 碳酸是一种快速有效的治疗 flecainide 心脏毒性.
更多相关视频
16:40A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
10:41Laser-Induced Action Potential-Like Measurements of Cardiomyocytes on Microelectrode Arrays for Increased Predictivity of Safety Pharmacology
Published on: September 13, 2022
相关概念视频
Prevention of Further Absorption of Poison
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
